Clinical Trials for HaploX Biotechnology

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: HaploX Biotechnology

Clinical Trials (5)

NCT05980689
Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer
PHASE2Recruiting
33 participants
Started: Oct 24, 2023 · Completed: Jan 31, 2025
1 condition3 sponsors1 location
NCT05533892
Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC
PHASE1Recruiting
30 participants
Started: Sep 1, 2022 · Completed: Feb 28, 2025
1 condition10 sponsors1 location
NCT05717738
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
N/ARecruiting
300 participants
Started: Jan 20, 2022 · Completed: Dec 31, 2024
1 condition6 sponsors4 locations
NCT05713994
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/ARecruiting
300 participants
Started: May 19, 2020 · Completed: Dec 30, 2025
1 condition6 sponsors2 locations
NCT05520801
Primary Hepatobiliary Cancer Cohort of Central China
N/ARecruiting
2,000 participants
Started: May 1, 2020 · Completed: Mar 31, 2025
2 conditions7 sponsors1 location